Doctor Pia Lundman
Karolinska Institute, Stockholm (Sweden)
Membership:
FESC Member
Follow
Contributor content
Journal
Utilization and discontinuation of secondary prevention pharmacotherapy after myocardial infarction: a nationwide cohort study
4 November 2025
Journal
Eligibility for lipid-lowering therapy when applying systemic coronary risk estimation 2 according to guidelines on apparently healthy middle-aged individuals
6 June 2024
Journal
Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013–17
6 March 2020
Journal
Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study
18 February 2020
Journal
Glucagon-like peptide-1 receptor agonists and the risk of cardiovascular events in diabetes patients surviving an acute myocardial infarction
30 January 2020
